CHRU Lille - Hôpital Claude Huriez; Service des Maladies du Sang

Lille 59037

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, Non-Hodgkin

Studies at this site

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma — Stopped early